Bristol-Myers Squibb Company News Headlines

BMY 
$50.25
*  
0.52
1.02%
Get BMY Alerts
*Delayed - data as of Aug. 27, 2014  -  Find a broker to begin trading BMY now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    BMY After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

6 Great Dividend Plays Heading Into 2013
10/31/2012 3:55:00 PM - Seeking Alpha

Now Could Be The Time To Speculate On Achillion Pharmaceuticals
10/30/2012 11:20:00 AM - Seeking Alpha

Avoid This Big Pharma As New Regulations Churn
10/29/2012 4:07:00 PM - Seeking Alpha

Bristol-Myers Squibb: Investors Can Focus On The Future After Plavix
10/29/2012 5:43:00 AM - Seeking Alpha

Retirement Strategy: Dialing Up Team Alpha's Dividends
10/26/2012 3:48:00 PM - Seeking Alpha

Buy Gilead Sciences: HIV And Hepatitis Drugs To Drive Growth
10/25/2012 6:22:00 AM - Seeking Alpha

Bristol-Myers Sales Slump 30% on Generic Pressure
10/24/2012 10:24:00 AM - Fox Business

Whisper Number Impact: Earnings Preview For Kimberly-Clark, Eli Lilly, And Bristol-Myers
10/24/2012 1:25:00 AM - Seeking Alpha

Bristol Myers' Plavix Patent Cliff Will Weigh On Results
10/23/2012 6:58:00 PM - Seeking Alpha

Should Investors Be Concerned About Eli Lilly?
10/23/2012 10:04:00 AM - Seeking Alpha

Lpathomab Offers Hope In Billion-Dollar Neurotrauma And Pain Markets
10/22/2012 6:19:00 PM - Seeking Alpha

Week Ahead: FOMC Meeting and Earnings
10/19/2012 1:58:00 PM - Fox Business

Players In Hepatitis C Treatment Market Officially In Play
10/19/2012 12:13:00 PM - Seeking Alpha

Using Options To Benefit From The Binary Nature Of FDA Decisions
10/18/2012 8:15:00 AM - Seeking Alpha

7 High-Yield Dividend Stocks The Top Investors Are Buying
10/17/2012 5:35:00 PM - Seeking Alpha

Unique Approach Gives Sanofi An Edge
10/16/2012 5:07:00 PM - Seeking Alpha

Notable Insider Sells Filed On October 15
10/16/2012 3:27:00 AM - Seeking Alpha

Celgene: Was Abraxis Worth It?
10/15/2012 4:55:00 PM - Seeking Alpha

Johnson & Johnson: A Long-Time Bear Turns Bullish Before Earnings
10/15/2012 9:28:00 AM - Seeking Alpha

5 Top Pharmaceuticals Paying Substantial Dividends
10/14/2012 6:22:00 AM - Seeking Alpha

Bristol Myers' Competition Causes Increased Risk
10/11/2012 11:29:00 AM - Seeking Alpha

Novo Nordisk Is Positioned To Profit Off Of Obesity Epidemic But Price May Be Rich
10/9/2012 6:19:00 AM - Seeking Alpha

Avoid These Bonds And Do This Instead
10/8/2012 2:52:00 PM - Seeking Alpha

Retirement Strategy: 'Team Alpha' Re-Balances For Balance, With Allocation
10/6/2012 12:43:00 PM - Seeking Alpha

Vorapaxar For Patients With Previous MI And Merck's Bottom Line
10/5/2012 4:54:00 PM - Seeking Alpha